Dr. Eufrosina I. Young, MD

Dr. Young practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Young's NPI, 1710968730, was assigned on November 8, 2005. Dr. Young holds New York license 237766.

Dr. Young's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Young's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. The medical group on file is Department of Neurology at SUNY Upstate Medical University. Dmand AI also links Dr. Young to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Young is licensed in New York.

CMS data shows 566 Medicare services from Dr. Young across 10 procedure codes in 2024, for 145 Medicare patients. Medicare paid $28,454 for them.

CMS counts 145 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 60, with 50% women.

In 2024, Dr. Young wrote 664 Medicare Part D claims for 89 patients. 67% of them were for generic drugs. CMS names the drug for 565 of them, across 16 drugs with 11 or more claims each, at $2,043,600 in total drug cost. In 2023, CMS named 593 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Young for performance year 2024, reported as part of a group. Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Young as offering telehealth.

Dmand AI links 9 papers to Dr. Young, published from 2017 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Amyotrophic Lateral Sclerosis, Evoked Potentials, Motor and Muscle, Skeletal. Dr. Young has published most often in Exp Brain Res. Dr. Young's most frequent co-authors are Stephen Aaron Goutman, MD, Daragh Heitzman, MD and Eduardo R. Locatelli, MD, MPH.

Dmand AI links Dr. Young to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis and TDP-43 Proteinopathies.

CMS Open Payments shows 23 general payments to Dr. Young from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 83% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $7,523.